Position in JAZZ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$106,779,348
+$14,397,987 QoQ
Shares Held
443,123
-9.3% QoQ
Ownership
0.683%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#32
of 640 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Boston Trust Walden Corp holds $230,816,361 across 5 Biotechnology names. JAZZ ranks #1 (46.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
443,123 | $106,779,348 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,083,062 | $84,771,262 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
440,264 | $38,280,954 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,193 | $743,883 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
485 | $240,914 |
All Filings in JAZZ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $106,779,348 | 443,123 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $92,381,361 | 488,661 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $66,964,870 | 393,911 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $53,883,398 | 408,827 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $43,286,028 | 407,897 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $22,100,189 | 178,012 | Shares | Defined | 2025-04-21 | |
| No filing history on record for this holder in this stock. | ||||||